课题基金 / 基金详情

Neuro-ophthalmic Mechanisms Of Disease

Neuro-ophthalmic Mechanisms Of Disease
疾病的神经眼科机制
批准号:
9362374
负责人:
Edmond J FitzGibbon
金额:
$25.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Edmond J FitzGibbon的其他基金

相似基金

相关文献

中文摘要
翻译
在这份报告中,我将集中于各种具有特征性眼球运动异常的疾病的研究,以及影响视力或具有神经眼科后果的疾病,如纤维结构不良和神经纤维瘤病。 眼球运动控制分布在整个大脑中,影响大脑部分的疾病可以以不同的、往往是特定的方式影响眼球运动。我们记录了神经退行性和遗传性疾病患者的眼球运动,以表征他们的眼球运动障碍,帮助做出特定的诊断,将表型与基因相关,疾病进展阶段,并洞察眼球运动产生的潜在过程。 纤维异常增殖症(FD)是一种正常骨骼被纤维骨组织取代的疾病。麦考恩-奥尔布赖特综合征的患者有多发性骨化性纤维异常增殖症、内分泌异常和咖啡色斑点。在McCune Albright综合征中,前颅底经常受累,包括蝶骨。视神经穿过蝶骨翼,在CT影像上常可见其被FD包裹。由于视神经病变导致视力丧失是最常见的神经系统并发症,对包绕视神经的纤维异常增殖症的处理是有争议的。与牙科研究所的迈克尔·柯林斯博士合作,对90多名纤维结构不良患者继续进行纵向追踪神经眼科检查,以追踪这种疾病的自然病史。我们在这个队列中的经验是,视神经病变是不常见的,我们建议不要进行手术减压。生长激素水平高的患者有患视神经病变的风险,但如果生长激素过量可以控制的话就不会。我们继续对这些患者进行纵向跟踪,柯林斯博士的团队继续招募麦克库恩·奥尔布赖特综合征患者。 神经纤维瘤病1型(NF1)是一种常见的常染色体显性遗传病。丛状神经纤维瘤发生在大约25%的患者中,这是NF1最令人虚弱的并发症之一。中枢神经系统胶质瘤和其他神经眼科症状的发生率也较高。与NCI的Brigitte Widemann合作,参加自然疾病研究的NF1患者继续在眼科诊所接受检查。观察指标包括LISCH结节、视力、眼球运动和眼睑功能。进行完整的神经眼科检查和成像。威德曼博士领导的一项新研究涉及眼眶和视觉通路丛状神经纤维瘤的患者。这些患者接受实验性的MEK抑制剂,希望减少或阻止肿瘤生长。他们在研究期间接受基线和持续的神经眼科检查。 Erdheim Chester病是一种罕见的组织细胞增多症,通常发生在患者的50岁左右。在长骨、腹膜后间隙、肾脏、肺和眼眶等间隙中可以发现组织细胞的聚集。在眼眶内出现会导致眼球突出、复视和视神经病变。我们正在纵向跟踪一组Erdheim Chester患者与Juvianee Estrada Veras博士的神经眼科发现。眼眶受累并不常见,我们的队列中只有不到20%的人表现出眼眶质量。 在与NEI的Boris Sheliga、Christian Quaia和Bruce Cumming的合作下,我们继续使用NEI的Fred Miles首创的眼睛跟随反应技术来探索视觉运动系统。这些方法使用机器一样的眼球运动来响应不同的刺激,以帮助理解运动视觉背后的机制。在过去的一年里,实验证明了人类视觉系统的早期阶段是如何限制眼球跟随反应的。 Lance Optican博士和Elena Pretgiani Parkinson病患者记录了患者在间隙/重叠扫视任务中的眼球运动。帕金森病患者的行为和知觉的时间耦合性受损。 在NIH临床中心,在Francis Collins博士和Irini Manoli博士以及许多其他合作者的领导下,开始了一项针对Moebius综合征和相关疾病患者的外部/内部合作研究。到目前为止,NIH和其他学术机构已经对几名患者进行了评估。目标包括这些患有罕见的先天性眼外肌和脑神经问题的患者的表型-基因相关性。这些患者都接受了完整的神经眼科评估,通常还会进行外显子组和其他专门的基因组测序,以及其他测试,以确定他们的疾病特征。
英文摘要
In this report I will concentrate on studies of various diseases which have characteristic oculomotor abnormalities, and also on diseases that affect vision, or have neuro-ophthalmic consequences, such as fibrous dysplasia and neurofibromatosis. Oculomotor control is distributed throughout the brain, and diseases affecting parts of the brain can affect eye movements in different, and often specific ways. We have recorded eye movements in patients with neurodegenerative and genetic diseases to characterize their ocular motility disorder, to help make a specific diagnosis, to correlate phenotype to genotype, to stage disease progression, and to give insight into the processes underlying eye movement generation. Fibrous dysplasia (FD) is a disease where normal bone is replaced with fibro-osseous tissue. Patients with McCune Albright syndrome have polyostotic fibrous dysplasia, endocrine abnormalities, and cafe au lait spots. In McCune Albright syndrome, the anterior cranial base is frequently involved, including the sphenoid bones. The optic nerve passes through the sphenoid wing and is often found to be encased by FD on CT imaging. The management of fibrous dysplasia encased optic nerves is controversial, as optic neuropathy resulting in vision loss is the most frequently reported neurological complication. In collaboration with Dr. Michael Collins of the Dental Institute, a cohort of more than 90 patients with fibrous dysplasia continue to be followed longitudinally with neuro-ophthalmologic exams to track the natural history of this disease. Our experience in this cohort is that optic neuropathy is unusual and we recommend that surgical decompression not be done. Patients with high growth hormone are at risk for optic neuropathy but not if the growth hormone excess can be controlled. We continue to longitudinally follow these patients and Dr. Collins' group continues to recruit patients with McCune Albright syndrome. Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder. Plexiform neurofibromas develop in about 25% of patients and these are among the most debilitating complication of NF1. There is also a higher incidence of central nervous system gliomas and other neuro-ophthalmic manifestations. In collaboration with Brigitte Widemann of NCI, NF1 patients enrolled in a natural disease study continue to be examined in the eye clinic. Several parameters are followed including Lisch nodules, vision, ocular motility and lid function. Complete neuro-ophthalmic exams and imaging are performed. A new study headed by Dr. Widemann involves patients with plexiform neurofibromas of the orbit and visual pathways. These patients receive an experimental MEK inhibitor in hopes of decreasing or arresting tumor growth. They receive baseline and ongoing neuro-ophthalmic exams during the study. Erdheim Chester disease is a rare histiocytosis typically developing in patient in their 5th decade of life. Collections of histiocytes may be found in the long bones, retroperitoneal space, in the kidneys, lungs and the orbits among other spaces. Presentation in the orbit can lead to proptosis, diplopia, and optic neuropathy. We are longitudinally following a cohort of Erdheim Chester patients with Dr. Juvianee Estrada Veras for neuro-ophthalmic findingss. Orbital involvement is uncommon with less than 20% of our cohort demonstrating orbital masses. In collaboration with Boris Sheliga, Christian Quaia, and Bruce Cumming of the NEI, we continue to probe the visual motion system using ocular following response techniques pioneered by Fred Miles of the NEI. These approaches use the machine like eye movements made in response to differing stimuli to help understand the mechanisms underlying motion vision. In the past year experiments demonstrated how ocular following responses are constrained by early stages of the human visual system. With Drs. Lance Optican and Elena Pretgiani Parkinson disease patients' eye movements were recorded in response to gap/overlap saccadic tasks. Impaired temporal coupling of action and perception was found in Parkinsons disease. An extramural/intramural collaborative study at the NIH Clinical Center of patients with Moebius syndrome and related disorders started under the leadership of Dr. Francis Collins and Dr. Irini Manoli, along with many other collaborators. Several patients have been evaluated to date at NIH and other academic institutions. The goals include phenotype-genotype correlation of these patients who have unusual congenital extraocular muscle and cranial nerve problems. These patients all undergo complete neuro-ophthalmic assessment and often exome and other specialized genome sequencing, along with other testing in order to characterize their disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuro-ophthalmic Mechanisms Of Disease
  • 批准号:
    6826927
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Edmond J FitzGibbon
  • 依托单位:
Neuro-ophthalmic Mechanisms Of Disease
  • 批准号:
    7322372
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Edmond J FitzGibbon
  • 依托单位:
Neuro-ophthalmic Mechanisms Of Disease
  • 批准号:
    10706104
  • 项目类别:
  • 资助金额:
    $38.51万
  • 财政年份:
    --
  • 负责人:
    Edmond J FitzGibbon
  • 依托单位:
Neuro-ophthalmic Mechanisms Of Disease
  • 批准号:
    8339766
  • 项目类别:
  • 资助金额:
    $29.5万
  • 财政年份:
    --
  • 负责人:
    Edmond J FitzGibbon
  • 依托单位:
海外基金